The Effect of Chronic Altitude Exposure on COPD Outcomes in the SPIROMICS Cohort.
Suri R, Markovic D, Woo H, Arjomandi M, Barr RG, Bowler RP, Criner G, Curtis JL, Dransfield MT, Drummond MB, Fortis S, Han MK, Hoffman EA, Kaner RJ, Kaufman JD, Krishnan JA, Martinez FJ, Ohar J, Ortega VE, Paine Iii R, Soler X, Woodruff PG, Hansel NN, Cooper CB, Tashkin DP, Buhr RG, Barjaktarevic IZ.
Suri R, et al.
Am J Respir Crit Care Med. 2024 Mar 20. doi: 10.1164/rccm.202310-1965OC. Online ahead of print.
Am J Respir Crit Care Med. 2024.
PMID: 38507607
METHODS: From the SPIROMICS cohort, we identified individuals with COPD living below 1,000 ft (305 m) elevation (n= 1,367) versus above 4,000 ft (1,219 m) elevation (n= 288). ...MEASUREMENTS AND MAIN RESULTS: Living at higher altitude was associated with reduced fun …
METHODS: From the SPIROMICS cohort, we identified individuals with COPD living below 1,000 ft (305 m) elevation (n= 1,367) versus abo …